Brief: Aft Pharmaceuticals Broadens R+D Pipeline With New Product Candidate

AFT Pharmaceuticals

21/12/2023 22:54

Dec 22 (Reuters) - AFT Pharmaceuticals Ltd  AFT.NZ :
    * AFT BROADENS R+D PIPELINE WITH NEW PRODUCT CANDIDATE
    * AFT BROADENS RESEARCH AND DEVELOPMENT PIPELINE WITH NEW
PRODUCT
CANDIDATE IN  BURNING MOUTH SYNDROME
    * UNDER AGREEMENT, CO & HYLORIS WILL CO-INVEST FOR
DEVELOPMENT OF
HY-090 FOR PURPOSE OF REGISTRATION, APPROVAL & COMMERCIALISATION
    * ENTERED INTO A PARTNERSHIP WITH BELGIUM'S HYLORIS
PHARMACEUTICALS
    * PARTNERSHIP TO DEVELOP A NOVEL LOCALLY ACTING PRODUCT FOR
TREATMENT OF BURNING MOUTH SYNDROME

Source text for Eikon:  ID: 
Further company coverage:  AFT.NZ 

 ((Reuters.Briefs@thomsonreuters.com;))